Copyright Reports & Markets. All rights reserved.

Global Proteomics Market Size, Status and Forecast 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Proteomics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Proteomics Instruments
      • 1.4.3 Proteomics Reagents
      • 1.4.4 Proteomics Services
      • 1.4.5 Proteomics Software
    • 1.5 Market by Application
      • 1.5.1 Global Proteomics Market Share by Application (2014-2025)
      • 1.5.2 Clinical Diagnostics
      • 1.5.3 Drug Discovery
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Proteomics Market Size
    • 2.2 Proteomics Growth Trends by Regions
      • 2.2.1 Proteomics Market Size by Regions (2014-2025)
      • 2.2.2 Proteomics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Proteomics Market Size by Manufacturers
      • 3.1.1 Global Proteomics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Proteomics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Proteomics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Proteomics Key Players Head office and Area Served
    • 3.3 Key Players Proteomics Product/Solution/Service
    • 3.4 Date of Enter into Proteomics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Proteomics Market Size by Type (2014-2019)
    • 4.2 Global Proteomics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Proteomics Market Size (2014-2019)
    • 5.2 Proteomics Key Players in United States
    • 5.3 United States Proteomics Market Size by Type
    • 5.4 United States Proteomics Market Size by Application

    6 Europe

    • 6.1 Europe Proteomics Market Size (2014-2019)
    • 6.2 Proteomics Key Players in Europe
    • 6.3 Europe Proteomics Market Size by Type
    • 6.4 Europe Proteomics Market Size by Application

    7 China

    • 7.1 China Proteomics Market Size (2014-2019)
    • 7.2 Proteomics Key Players in China
    • 7.3 China Proteomics Market Size by Type
    • 7.4 China Proteomics Market Size by Application

    8 Japan

    • 8.1 Japan Proteomics Market Size (2014-2019)
    • 8.2 Proteomics Key Players in Japan
    • 8.3 Japan Proteomics Market Size by Type
    • 8.4 Japan Proteomics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Proteomics Market Size (2014-2019)
    • 9.2 Proteomics Key Players in Southeast Asia
    • 9.3 Southeast Asia Proteomics Market Size by Type
    • 9.4 Southeast Asia Proteomics Market Size by Application

    10 India

    • 10.1 India Proteomics Market Size (2014-2019)
    • 10.2 Proteomics Key Players in India
    • 10.3 India Proteomics Market Size by Type
    • 10.4 India Proteomics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Proteomics Market Size (2014-2019)
    • 11.2 Proteomics Key Players in Central & South America
    • 11.3 Central & South America Proteomics Market Size by Type
    • 11.4 Central & South America Proteomics Market Size by Application

    12 International Players Profiles

    • 12.1 Thermo Fisher Scientific
      • 12.1.1 Thermo Fisher Scientific Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Proteomics Introduction
      • 12.1.4 Thermo Fisher Scientific Revenue in Proteomics Business (2014-2019)
      • 12.1.5 Thermo Fisher Scientific Recent Development
    • 12.2 Agilent
      • 12.2.1 Agilent Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Proteomics Introduction
      • 12.2.4 Agilent Revenue in Proteomics Business (2014-2019)
      • 12.2.5 Agilent Recent Development
    • 12.3 Merck KGaA
      • 12.3.1 Merck KGaA Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Proteomics Introduction
      • 12.3.4 Merck KGaA Revenue in Proteomics Business (2014-2019)
      • 12.3.5 Merck KGaA Recent Development
    • 12.4 Danaher
      • 12.4.1 Danaher Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Proteomics Introduction
      • 12.4.4 Danaher Revenue in Proteomics Business (2014-2019)
      • 12.4.5 Danaher Recent Development
    • 12.5 Waters
      • 12.5.1 Waters Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Proteomics Introduction
      • 12.5.4 Waters Revenue in Proteomics Business (2014-2019)
      • 12.5.5 Waters Recent Development
    • 12.6 Bio-Rad Laboratories
      • 12.6.1 Bio-Rad Laboratories Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Proteomics Introduction
      • 12.6.4 Bio-Rad Laboratories Revenue in Proteomics Business (2014-2019)
      • 12.6.5 Bio-Rad Laboratories Recent Development
    • 12.7 Bruker
      • 12.7.1 Bruker Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Proteomics Introduction
      • 12.7.4 Bruker Revenue in Proteomics Business (2014-2019)
      • 12.7.5 Bruker Recent Development
    • 12.8 GE Healthcare
      • 12.8.1 GE Healthcare Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Proteomics Introduction
      • 12.8.4 GE Healthcare Revenue in Proteomics Business (2014-2019)
      • 12.8.5 GE Healthcare Recent Development
    • 12.9 PerkinElmer
      • 12.9.1 PerkinElmer Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Proteomics Introduction
      • 12.9.4 PerkinElmer Revenue in Proteomics Business (2014-2019)
      • 12.9.5 PerkinElmer Recent Development
    • 12.10 Luminex
      • 12.10.1 Luminex Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Proteomics Introduction
      • 12.10.4 Luminex Revenue in Proteomics Business (2014-2019)
      • 12.10.5 Luminex Recent Development
    • 12.11 Creative Proteomics
    • 12.12 Promega
    • 12.13 LI-COR
    • 12.14 HORIBA
    • 12.15 Becton, Dickinson
    • 12.16 Biognosys
    • 12.17 Proteomics International
    • 12.18 DC Biosciences
    • 12.19 G-Biosciences
    • 12.20 Bioproximity

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Proteomics is the study of the structure and functions of proteins that are used in drug discovery, diagnosis, and treatment of diseases. A proteome is never constant as it differs from one cell to other with time. Proteomics is used to evaluate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Structural proteomics is used to identify the structure of protein complexes, while functional proteomics is used for characterizing the protein‐protein interactions to demonstrate protein functions. In this report, the proteomics market is segmented by instrument, reagent, and services & software.
      In 2018, the global Proteomics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Proteomics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Proteomics development in United States, Europe and China.

      The key players covered in this study
      Thermo Fisher Scientific
      Agilent
      Merck KGaA
      Danaher
      Waters
      Bio-Rad Laboratories
      Bruker
      GE Healthcare
      PerkinElmer
      Luminex
      Creative Proteomics
      Promega
      LI-COR
      HORIBA
      Becton, Dickinson
      Biognosys
      Proteomics International
      DC Biosciences
      G-Biosciences
      Bioproximity

      Market segment by Type, the product can be split into
      Proteomics Instruments
      Proteomics Reagents
      Proteomics Services
      Proteomics Software

      Market segment by Application, split into
      Clinical Diagnostics
      Drug Discovery
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Proteomics status, future forecast, growth opportunity, key market and key players.
      To present the Proteomics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Proteomics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now